drugset / Trial / NCT06168994

Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease

NCT06168994

Phase 4 Not yet recruiting 100 enrolled Assiut University
RandomizedParallel-groupSingle-blindPrevention

Summary

The aim of this study is to study synergistic effect of eplerenone as Selective aldosterone receptor antagonist with amiodarone compared with amiodarone only in reducing recurrence of atrial fibrillation in patient with structural heart disease

Timeline

Start
2024-02-01
Primary completion
2026-09-29
Completion
2027-05-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown